BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 16520725)

  • 21. [Diagnosis of thrombophilia based on coagulation and genetic studies].
    Bałszan-Kowalska I
    Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombophilic disorders in venous thromboembolism. The clinical perspective].
    Schmidt B; Schellong S
    Med Klin (Munich); 2003 Mar; 98(3):133-9. PubMed ID: 12647087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inherited thrombophilic risk factors in a large cohort of individuals referred to Italian thrombophilia centers: distinct roles in different clinical settings.
    Margaglione M; Brancaccio V; Ciampa A; Papa ML; Grandone E; Di Minno G
    Haematologica; 2001 Jun; 86(6):634-9. PubMed ID: 11418373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis.
    Baba-Ahmed M; Le Gal G; Couturaud F; Lacut K; Oger E; Leroyer C
    Thromb Haemost; 2007 Feb; 97(2):171-5. PubMed ID: 17264942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Thrombophilia risk factors evaluation in a group of Italian patients with deep venous thrombosis].
    Valverde S; Antico F; Trabuio E; Basso D; Navaglia F; Orlandini E; Giacomini A; Manoni F; Gessoni G
    Recenti Prog Med; 2008; 99(7-8):348-53. PubMed ID: 18751613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Who should be tested for thrombophilia?
    Simioni P
    Curr Opin Hematol; 2006 Sep; 13(5):337-43. PubMed ID: 16888438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphism in the beta2-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: a multilocus, population-based, prospective genetic analysis.
    Zee RY; Cook NR; Cheng S; Erlich HA; Lindpaintner K; Ridker PM
    Circulation; 2006 May; 113(18):2193-200. PubMed ID: 16651467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis.
    Wysokinska EM; Wysokinski WE; Brown RD; Karnicki K; Gosk-Beirska I; Grill D; McBane RD
    Neurology; 2008 Feb; 70(8):627-33. PubMed ID: 18285537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is plasminogen deficiency a thrombotic risk factor? A study on 23 thrombophilic patients and their family members.
    Demarmels Biasiutti F; Sulzer I; Stucki B; Wuillemin WA; Furlan M; Lämmle B
    Thromb Haemost; 1998 Jul; 80(1):167-70. PubMed ID: 9684804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inherited thrombophilia].
    De Stefano V
    G Ital Nefrol; 2009; 26 Suppl 46():14-9. PubMed ID: 19644814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombophilia in children with venous thromboembolic disease.
    Revel-Vilk S; Kenet G
    Thromb Res; 2006; 118(1):59-65. PubMed ID: 15993476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis. Results from the MAISTHRO registry.
    Linnemann B; Meister F; Schwonberg J; Schindewolf M; Zgouras D; Lindhoff-Last E;
    Thromb Haemost; 2008 Sep; 100(3):440-6. PubMed ID: 18766260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Legg-Calve-Perthes disease, venous and arterial thrombi, and the factor V Leiden mutation in a four-generation kindred.
    Glueck CJ; Tracy T; Wang P
    J Pediatr Orthop; 2007; 27(7):834-7. PubMed ID: 17878795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study.
    Baglin T; Luddington R; Brown K; Baglin C
    Lancet; 2003 Aug; 362(9383):523-6. PubMed ID: 12932383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thrombophilic conditions in the pathogenesis of venous thromboembolism].
    Poul H
    Vnitr Lek; 2006 Mar; 52 Suppl 1():17-25. PubMed ID: 16637445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of thrombophilia screening in an urban tertiary care medical center: A "real world" experience.
    Somma J; Sussman II; Rand JH
    Am J Clin Pathol; 2006 Jul; 126(1):120-7. PubMed ID: 16753592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombophilia and risk of venous thrombosis in patients with cancer.
    Decousus H; Moulin N; Quenet S; Bost V; Rivron-Guillot K; Laporte S; Mismetti P
    Thromb Res; 2007; 120 Suppl 2():S51-61. PubMed ID: 18023713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombophilia in venous leg ulcers: a comparative study in early and later onset.
    Calistru AM; Baudrier T; Gonçalves L; Azevedo F
    Indian J Dermatol Venereol Leprol; 2012; 78(3):406. PubMed ID: 22565455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary thrombophilia and venous thromboembolism: critical evaluation of the clinical implications of screening.
    Mazzolai L; Duchosal MA
    Eur J Vasc Endovasc Surg; 2007 Oct; 34(4):483-8. PubMed ID: 17588784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombophilia and cancer.
    Horowitz N; Brenner B
    Pathophysiol Haemost Thromb; 2008; 36(3-4):131-6. PubMed ID: 19176986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.